Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Many if not most hospitals and other provider organizations take a decided interest in what their peer institutions are doing with AI. A major motivator for the keen curiosity is gauging how well one is keeping up with the Joneses. So to speak.
The FTC has put its price collusion case against CVS Caremark, Optum Rx and Express Scripts on hold after significant staff departures at the agency left it uncertain how to proceed
Questions remain about the alleged breach on a legacy server at Oracle Health, as the nature of the attacks and scope of stolen data are still being investigated.
A legacy server accessed with stolen credentials is being blamed for the incident. However, the nature and scope of the attack are still being investigated, with Oracle reportedly working with the FBI to gather details.
A radiologist running the Boston Marathon with his daughter, a pediatrician, were among the first health care providers on the scene after bombs exploded at the finish line of the race
A report out today from the Kaiser Family Foundation (KFF) adds urgency to efforts to repeal the SGR formula and keep the pressure on health care cost containment
A new ASRT white paper sounds a warning about technologist training and staffing challenges in an era of shrinking imaging reimbursement and rapid technological change, but also offers ways to correct these issues
New Orleans-based Cook Medical took the opportunity of the SIR meeting to introduce its new fully-retractable .035 inch embolization coil for peripheral arterial and venous embolization
The patent covers a system for monitoring the portions of a medical image displayed at full resolution and reducing the chance of a missing an abnormality in the image due to the viewer examining a portion of the image at a different resolution or other display parameter.
Eli Lilly, the maker of the first FDA-approved Alzheimer's imaging agent, Amyvid, is acquiring two imaging agents developed by Siemens that make brain deposits of tau visible. Amyvid targets amyloid plaques
The technique pairs laser optics with ultrasound imaging to create multispectral photoacoustic imaging that reliably sorted malignant prostate tissue samples from benign samples
The studies will help fulfill the Harvey L. Neiman Health Policy Institute's mission of creating a fuller evidence-based picture of the role of radiology in evolving health care delivery and payment models